212 related articles for article (PubMed ID: 29570070)
1. A Unified Mathematical Model for Nano-Liposomal Drug Delivery to Solid Tumors.
Asemani D; Haemmerich D
IEEE Trans Nanobioscience; 2018 Mar; 17(1):3-11. PubMed ID: 29570070
[TBL] [Abstract][Full Text] [Related]
2. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model.
Gasselhuber A; Dreher MR; Rattay F; Wood BJ; Haemmerich D
PLoS One; 2012; 7(10):e47453. PubMed ID: 23082168
[TBL] [Abstract][Full Text] [Related]
3. Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy.
Rezaeian M; Sedaghatkish A; Soltani M
Drug Deliv; 2019 Dec; 26(1):898-917. PubMed ID: 31526065
[TBL] [Abstract][Full Text] [Related]
4. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
[TBL] [Abstract][Full Text] [Related]
5. A systematic study of temperature sensitive liposomal delivery of doxorubicin using a mathematical model.
Liu C; Xu XY
Comput Biol Med; 2015 May; 60():107-16. PubMed ID: 25817532
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
Moosavian SA; Abnous K; Badiee A; Jaafari MR
Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
[TBL] [Abstract][Full Text] [Related]
7. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
[TBL] [Abstract][Full Text] [Related]
8. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
[TBL] [Abstract][Full Text] [Related]
9. Tumor-penetrating Peptide-integrated Thermally Sensitive Liposomal Doxorubicin Enhances Efficacy of Radiofrequency Ablation in Liver Tumors.
Yan F; Wang S; Yang W; Goldberg SN; Wu H; Duan WL; Deng ZT; Han HB; Zheng HR
Radiology; 2017 Nov; 285(2):462-471. PubMed ID: 28631963
[TBL] [Abstract][Full Text] [Related]
10. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
11. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
Santos MA; Goertz DE; Hynynen K
Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
[TBL] [Abstract][Full Text] [Related]
12. Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein.
Wang T; Hartner WC; Gillespie JW; Praveen KP; Yang S; Mei LA; Petrenko VA; Torchilin VP
Nanomedicine; 2014 Feb; 10(2):421-30. PubMed ID: 24028893
[TBL] [Abstract][Full Text] [Related]
13. Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
Manzoor AA; Lindner LH; Landon CD; Park JY; Simnick AJ; Dreher MR; Das S; Hanna G; Park W; Chilkoti A; Koning GA; ten Hagen TL; Needham D; Dewhirst MW
Cancer Res; 2012 Nov; 72(21):5566-75. PubMed ID: 22952218
[TBL] [Abstract][Full Text] [Related]
14. New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage.
Cern A; Marcus D; Tropsha A; Barenholz Y; Goldblum A
J Control Release; 2017 Apr; 252():18-27. PubMed ID: 28215669
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, Tissue Distribution and Therapeutic Effect of Cationic Thermosensitive Liposomal Doxorubicin Upon Mild Hyperthermia.
Dicheva BM; Seynhaeve AL; Soulie T; Eggermont AM; Ten Hagen TL; Koning GA
Pharm Res; 2016 Mar; 33(3):627-38. PubMed ID: 26518763
[TBL] [Abstract][Full Text] [Related]
16. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization.
Makwana V; Karanjia J; Haselhorst T; Anoopkumar-Dukie S; Rudrawar S
Int J Pharm; 2021 Jan; 593():120117. PubMed ID: 33259901
[TBL] [Abstract][Full Text] [Related]
17. Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes.
Dicheva BM; ten Hagen TL; Schipper D; Seynhaeve AL; van Rhoon GC; Eggermont AM; Koning GA
J Control Release; 2014 Dec; 195():37-48. PubMed ID: 25176578
[TBL] [Abstract][Full Text] [Related]
18. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.
Frenkel V; Etherington A; Greene M; Quijano J; Xie J; Hunter F; Dromi S; Li KC
Acad Radiol; 2006 Apr; 13(4):469-79. PubMed ID: 16554227
[TBL] [Abstract][Full Text] [Related]
19. Thermosensitive, near-infrared-labeled nanoparticles for topotecan delivery to tumors.
Rosca EV; Wright M; Gonitel R; Gedroyc W; Miller AD; Thanou M
Mol Pharm; 2015 May; 12(5):1335-46. PubMed ID: 25826624
[TBL] [Abstract][Full Text] [Related]
20. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
